Trial intelligence / Profile preview

PK/PD of Desmopressin Oral Lyophilisate in Children

NCT02584231Phase 4Completed

Sponsor
Ghent University
Start
Sep 2015
Primary completion
Mar 2018
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Ghent University. Primary endpoint: Desmopressin plasma concentrations at 24 hours. Started Sep 2015; status: completed.

02

Drugs

desmopressin
03

Conditions

nocturnal enuresis (NE)

Beyond the preview

Go deeper on NCT02584231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02584231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call